HIV Infection Linked to Elevated Risk for Sudden Cardiac Death in Veterans, New Study Shows
September 09, 2021

Patients with HIV had a 14% higher risk of sudden cardiac death than those without HIV, according to a large analysis of US veterans.

ESC 2021: Flu Vaccine Cuts Risk of Death, Heart Attack in Patients with Heart Disease
August 31, 2021

ESC Congress 2021: Results from the largest trial of its kind suggest that flu vaccination should be part of in-hospital treatment after myocardial infarction.

ESC 2021: Major Hypertension Trial Supports Tight BP Control with Data from Older Adults
August 31, 2021

Aggressive control of systolic BP in adults aged 60 to 80 years significantly reduced CV risk, adding to evidence from the pivotal SPRINT trial in support of tight BP control.

ESC 2021: Low-sodium Salt Alternative Found to Reduce Risk of Stroke
August 30, 2021

Substituting regular salt with low-sodium alternative was found to reduce the risk of stroke, major cardiovascular events, and death in a new study presented at ESC Congress 2021.

ESC 2021: Empagliflozin Found Beneficial in Patients with Heart Failure Regardless of Ejection Fraction
August 27, 2021

In a pooled analysis of 2 key clinical trials, empagliflozin was beneficial in patients with heart failure with a reduced and preserved ejection fraction.

New Study Suggests Link Between Saturated Fat and CVD Risk Varies by Food Source
August 26, 2021

Consuming saturated fat from meat may be associated with a higher risk of CVD than other food sources, according to a new study presented at ESC Congress 2021.

ESC 2021: Patients with Prior Myocardial Infarction and Gum Disease Face Higher Risk of Heart Disease
August 25, 2021

Periodontitis was associated with an increased risk for CVD, particularly among patients with past myocardial infarction, in a new study being presented at ESC Congress 2021.

ESC 2021: Despite Smoking Less, Women Find it Harder to Quit Than Men
August 25, 2021

New findings being presented at ESC Congress 2021 highlight the need for smoking cessation services tailored to the specific needs of women.

Rivaroxaban: New Indication for Use in PAD Following Lower Extremity Revascularization
August 25, 2021

With the post-LER PAD indication, rivaroxaban becomes the only anticoagulant in 2 decades to demonstrate safety and efficacy in the high-risk population.

ESC 2021: The Risk of Young-onset Heart Attack May Go Beyond Family History
August 24, 2021

Younger adults with myocardial infarction are more likely to be smokers, obese, and have hypertension than their peers, suggests a new study being presented at the ESC Congress 2021.